Mitsubishi UFJ Trust & Banking’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114K Buy
+13,610
New +$124K ﹤0.01% 1481
2026
Q1
Sell
-19,342
Closed -$353K 1099
2025
Q4
$353K Buy
19,342
+4,346
+29% +$73.2K ﹤0.01% 1009
2025
Q3
$220K Hold
14,996
﹤0.01% 1051
2025
Q2
$273K Buy
+14,996
New +$306K ﹤0.01% 965

Other funds holding ADMA

Mitsubishi UFJ Trust & Banking's ADMA Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in ADMA Biologics (ADMA) in Q2 2026: 13,610 shares worth $114K. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Mitsubishi UFJ Trust & Banking previously reported a position in ADMA as recently as Q4 2025.

Mitsubishi UFJ Trust & Banking first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $353K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 13,610 shares of ADMA Biologics worth $114K as of Q2 2026.
  • ADMA Biologics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1481 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • Mitsubishi UFJ Trust & Banking's ADMA Biologics position peaked at $353K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.